Jover Placid sold TEVA
August 3, 2026 · Form 4 insider transaction
Jover Placid sold 12,827 shares of Teva Pharmaceutical Industries Limited at $34.88 per share, a transaction worth $447.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.; The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.; Represents with respect to the vesting of restricted share units, the reporting person sold all such shares vested, including shares to cover tax witholding obligations in connection with the vesting.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.66 to $35.07, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.